Chiltern newsDAY

Publish Date:
October 11, 2016
Chiltern Staff

In this issue of newsDAY various thought leaders from Chiltern weigh in on the complex, global issues that surround drug development today.


  • Global Diagnostics Approval
  • Bringing MMAs to Market
  • Risk-Based Monitoring
  • Brexit
  • The Role of a CRO

Read more about these issues to gain a better understanding of how to successfully navigate the changing research environment